BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36843573)

  • 1. Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.
    Martinez-Mayer J; Perez-Millan MI
    Front Endocrinol (Lausanne); 2023; 14():1132787. PubMed ID: 36843573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
    McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism.
    Abreu AP; Kaiser UB; Latronico AC
    Neuroendocrinology; 2010; 91(4):283-90. PubMed ID: 20502053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
    Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallmann syndrome with a Tyr113His PROKR2 mutation.
    Ha JH; Lee S; Kim Y; Moon JI; Seo J; Jang JH; Cho EH; Kim JM; Rhee BD; Ko KS; Yoo SJ; Won JC
    Medicine (Baltimore); 2017 Sep; 96(35):e7974. PubMed ID: 28858133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
    Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
    Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kallmann syndrome: a historical [corrected] clinical and molecular review].
    Ribeiro RS; Abucham J
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):8-17. PubMed ID: 18345392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PROK2/PROKR2 signaling pathway is required for the migration of most olfactory bulb interneurons.
    Wen Y; Zhang Z; Li Z; Liu G; Tao G; Song X; Xu Z; Shang Z; Guo T; Su Z; Chen H; You Y; Li J; Yang Z
    J Comp Neurol; 2019 Dec; 527(18):2931-2947. PubMed ID: 31132148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
    Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
    Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.
    Martin C; Balasubramanian R; Dwyer AA; Au MG; Sidis Y; Kaiser UB; Seminara SB; Pitteloud N; Zhou QY; Crowley WF
    Endocr Rev; 2011 Apr; 32(2):225-46. PubMed ID: 21037178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
    Raivio T; Avbelj M; McCabe MJ; Romero CJ; Dwyer AA; Tommiska J; Sykiotis GP; Gregory LC; Diaczok D; Tziaferi V; Elting MW; Padidela R; Plummer L; Martin C; Feng B; Zhang C; Zhou QY; Chen H; Mohammadi M; Quinton R; Sidis Y; Radovick S; Dattani MT; Pitteloud N
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E694-9. PubMed ID: 22319038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROKR2 mutations in autosomal recessive Kallmann syndrome.
    Tommiska J; Toppari J; Vaaralahti K; Känsäkoski J; Laitinen EM; Noisa P; Kinnala A; Niinikoski H; Raivio T
    Fertil Steril; 2013 Mar; 99(3):815-8. PubMed ID: 23200691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic PROKR2 variants and congenital hypogonadotropic hypogonadism: a case report and a literature review.
    Sugisawa C; Taniyama M; Sato T; Takahashi Y; Hasegawa T; Narumi S
    Endocr J; 2022 Jul; 69(7):831-838. PubMed ID: 35236788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.